These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16354694)

  • 41. Phosphorylation at serine 28 and acetylation at lysine 9 of histone H3 induced by trichostatin A.
    Zhong S; Goto H; Inagaki M; Dong Z
    Oncogene; 2003 Aug; 22(34):5291-7. PubMed ID: 12917630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cell cycle-specific changes in hTERT promoter activity in normal and cancerous cells in adenoviral gene therapy: a promising implication of telomerase-dependent targeted cancer gene therapy.
    Murofushi Y; Nagano S; Kamizono J; Takahashi T; Fujiwara H; Komiya S; Matsuishi T; Kosai K
    Int J Oncol; 2006 Sep; 29(3):681-8. PubMed ID: 16865285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The 58-kda microspherule protein (MSP58) represses human telomerase reverse transcriptase (hTERT) gene expression and cell proliferation by interacting with telomerase transcriptional element-interacting factor (TEIF).
    Hsu CC; Chen CH; Hsu TI; Hung JJ; Ko JL; Zhang B; Lee YC; Chen HK; Chang WC; Lin DY
    Biochim Biophys Acta; 2014 Mar; 1843(3):565-79. PubMed ID: 24361335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells.
    Cong YS; Bacchetti S
    J Biol Chem; 2000 Nov; 275(46):35665-8. PubMed ID: 10986277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Follicle-stimulating hormone stimulates protein kinase A-mediated histone H3 phosphorylation and acetylation leading to select gene activation in ovarian granulosa cells.
    Salvador LM; Park Y; Cottom J; Maizels ET; Jones JC; Schillace RV; Carr DW; Cheung P; Allis CD; Jameson JL; Hunzicker-Dunn M
    J Biol Chem; 2001 Oct; 276(43):40146-55. PubMed ID: 11498542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential cis-regulation of human versus mouse TERT gene expression in vivo: identification of a human-specific repressive element.
    Horikawa I; Chiang YJ; Patterson T; Feigenbaum L; Leem SH; Michishita E; Larionov V; Hodes RJ; Barrett JC
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18437-42. PubMed ID: 16344462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells.
    Komata T; Kondo Y; Kanzawa T; Ito H; Hirohata S; Koga S; Sumiyoshi H; Takakura M; Inoue M; Barna BP; Germano IM; Kyo S; Kondo S
    Hum Gene Ther; 2002 Jun; 13(9):1015-25. PubMed ID: 12067435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Telomerase activation by histone deacetylase inhibitor in normal cells.
    Takakura M; Kyo S; Sowa Y; Wang Z; Yatabe N; Maida Y; Tanaka M; Inoue M
    Nucleic Acids Res; 2001 Jul; 29(14):3006-11. PubMed ID: 11452025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of the hTERT promoter by the proto-oncogenic protein TAL1.
    Terme JM; Mocquet V; Kuhlmann AS; Zane L; Mortreux F; Wattel E; Duc Dodon M; Jalinot P
    Leukemia; 2009 Nov; 23(11):2081-9. PubMed ID: 19587703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular mechanisms for the p38-induced cellular senescence in normal human fibroblast.
    Harada G; Neng Q; Fujiki T; Katakura Y
    J Biochem; 2014 Nov; 156(5):283-90. PubMed ID: 24920674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cot, a novel kinase of histone H3, induces cellular transformation through up-regulation of c-fos transcriptional activity.
    Choi HS; Kang BS; Shim JH; Cho YY; Choi BY; Bode AM; Dong Z
    FASEB J; 2008 Jan; 22(1):113-26. PubMed ID: 17724252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigenetic regulation of transcription factor promoter regions by low-dose genistein through mitogen-activated protein kinase and mitogen-and-stress activated kinase 1 nongenomic signaling.
    Yu L; Ham K; Gao X; Castro L; Yan Y; Kissling GE; Tucker CJ; Flagler N; Dong R; Archer TK; Dixon D
    Cell Commun Signal; 2016 Aug; 14(1):18. PubMed ID: 27582276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chromatin remodeling: recruitment of histone demethylase RBP2 by Mad1 for transcriptional repression of a Myc target gene, telomerase reverse transcriptase.
    Ge Z; Li W; Wang N; Liu C; Zhu Q; Björkholm M; Gruber A; Xu D
    FASEB J; 2010 Feb; 24(2):579-86. PubMed ID: 19762557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanism of telomerase repression during terminal differentiation of normal epithelial cells and squamous carcinoma lines.
    Crowe DL; Nguyen DC; Ohannessian A
    Int J Oncol; 2005 Sep; 27(3):847-54. PubMed ID: 16077937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon alpha down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cells.
    Xu D; Erickson S; Szeps M; Gruber A; Sangfelt O; Einhorn S; Pisa P; Grandér D
    Blood; 2000 Dec; 96(13):4313-8. PubMed ID: 11110707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The antiretroviral agent saquinavir enhances hTERT expression and telomerase activity in human T leukaemia cells in vitro.
    Adamo R; Comandini A; Aquino A; Bonmassar L; Guglielmi L; Bonmassar E; Franzese O
    J Exp Clin Cancer Res; 2013 Jun; 32(1):38. PubMed ID: 23759068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cells.
    Zhou C; Steplowski TA; Dickens HK; Malloy KM; Gehrig PA; Boggess JF; Bae-Jump VL
    PLoS One; 2013; 8(2):e55730. PubMed ID: 23409030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell line.
    Kawagoe J; Ohmichi M; Takahashi T; Ohshima C; Mabuchi S; Takahashi K; Igarashi H; Mori-Abe A; Saitoh M; Du B; Ohta T; Kimura A; Kyo S; Inoue M; Kurachi H
    J Biol Chem; 2003 Oct; 278(44):43363-72. PubMed ID: 12917431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf.
    Goueli BS; Janknecht R
    Mol Cell Biol; 2004 Jan; 24(1):25-35. PubMed ID: 14673140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG.
    Berletch JB; Liu C; Love WK; Andrews LG; Katiyar SK; Tollefsbol TO
    J Cell Biochem; 2008 Feb; 103(2):509-19. PubMed ID: 17570133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.